ASSESSMENT OF THE EFFECT OF DRUG FORMULATION ON THE EXTENT OF THE PHARMACOKINETIC INTERACTION BETWEEN VORICONAZOLE AND TACROLIMUS

被引:0
|
作者
Ott, Christian [2 ]
Huppertz, Andrea [2 ]
Foerster, Kathrin [2 ]
Burhenne, Juergen [2 ]
Weiss, Johanna [2 ]
Bruckner, Thomas [3 ]
Zorn, Markus [1 ]
Haefeli, Walter-Emil [2 ]
Czock, David [2 ]
机构
[1] Univ Hosp Heidelberg, Cent Lab, Heidelberg, Germany
[2] Univ Hosp Heidelberg, Dept Clin Pharmacol & Pharmacoepidemiol, Heidelberg, Germany
[3] Univ Hosp Heidelberg, Dept Med Biometry, Heidelberg, Germany
关键词
D O I
暂无
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
SP740
引用
收藏
页数:2
相关论文
共 50 条
  • [1] EFFECT OF DRUG FORMULATION ON THE EXTENT OF THE PHARMACOKINETIC INTERACTION BETWEEN VORICONAZOLE AND TACROLIMUS
    Ott, C.
    Huppertz, A.
    Foerster, K.
    Burhenne, J.
    Weiss, J.
    Bruckner, T.
    Zorn, M.
    Haefeli, W. E.
    Czock, D.
    TRANSPLANT INTERNATIONAL, 2018, 31 : 40 - 40
  • [2] Pharmacokinetic Drug Interaction between Tofacitinib and Voriconazole in Rats
    Lee, Ji-Sang
    Kim, Hyo-Sung
    Jung, Yong-Seob
    Choi, Hyeon-Gyeom
    Kim, So-Hee
    PHARMACEUTICS, 2021, 13 (05)
  • [3] Drug interaction between voriconazole and tacrolimus in allogeneic hematopoietic SCT recipients
    Mori, T.
    Kato, J.
    Yamane, A.
    Ono, Y.
    Shimizu, T.
    Okamoto, S.
    BONE MARROW TRANSPLANTATION, 2011, 46 (03) : 450 - 451
  • [4] Drug interaction between voriconazole and tacrolimus in allogeneic hematopoietic SCT recipients
    T Mori
    J Kato
    A Yamane
    Y Ono
    T Shimizu
    S Okamoto
    Bone Marrow Transplantation, 2011, 46 : 450 - 451
  • [5] Interaction between tacrolimus and voriconazole, a case report
    Ordorica Lopez, R.
    Cadenas Mancenido, A.
    Alvarez Cabrera, R. C.
    Sanchez Santiago, M. B.
    Vega Gil, N.
    Cos Cossio, M. A.
    Garcia Saiz, M. M.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2024, 135 : 44 - 44
  • [6] Clinically relevant drug interaction between voriconazole and tacrolimus in a primary renal allograft recipient
    Kuypers, Dirk R.
    Claes, Kathleen
    Evenepoel, Pieter
    Vanrenterghem, Yves
    TRANSPLANTATION, 2006, 81 (12) : 1750 - 1752
  • [7] Effect of CYP3A5*3 Polymorphism on Pharmacokinetic Drug Interaction between Tacrolimus and Amlodipine
    Zuo, Xiao-cong
    Zhou, Ya-nan
    Zhang, Bi-kui
    Yang, Guo-ping
    Cheng, Ze-neng
    Yuan, Hong
    Ouyang, Dong-sheng
    Liu, Shi-kun
    Barrett, Jeffrey S.
    Li, Pei-jiong
    Liu, Zhi
    Tan, Hong-yi
    Guo, Ren
    Zhou, Ling-yun
    Xie, Yue-liang
    Li, Zuo-jun
    Li, Jing
    Wang, Chun-jiang
    Wang, Jiang-lin
    DRUG METABOLISM AND PHARMACOKINETICS, 2013, 28 (05) : 398 - 405
  • [8] Individual dose recommendations for drug interaction between tacrolimus and voriconazole in adult liver transplant recipients: A semiphysiologically based population pharmacokinetic modeling approach
    Li, Zi-ran
    Shen, Cong-huan
    Li, Rui-dong
    Wang, Bei
    Li, Juan
    Niu, Wan-jie
    Zhang, Li-jun
    Zhong, Ming-kang
    Wang, Zheng-xin
    Qiu, Xiao-yan
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 184
  • [9] APPLICATION OF PHARMACOKINETIC DRUG INTERACTION BETWEEN DILTIAZEM AND TACROLIMUS IN CLINICAL RENAL TRANSPLANTATION
    Lim, T. S.
    Lou, H. X.
    Vathsala, A.
    NEPHROLOGY, 2005, 10 : A212 - A212
  • [10] Drug interaction between voriconazole and tacrolimus and its association with the bioavailability of oral voriconazole in recipients of allogeneic hematopoietic stem cell transplantation
    Mori, Takehiko
    Kato, Jun
    Yamane, Akiko
    Sakurai, Masatoshi
    Kohashi, Sumiko
    Kikuchi, Taku
    Ono, Yukako
    Okamoto, Shinichiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 95 (05) : 564 - 569